Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Breast Neoplasms 1061Neoplasms 887Prostatic Neoplasms 513Lung Neoplasms 426Colorectal Neoplasms 360Motor Activity 226Head and Neck Neoplasms 195Uterine Cervical Neoplasms 194Carcinoma, Non-Small-Cell Lung 182Brain Neoplasms 176Pancreatic Neoplasms 162Ovarian Neoplasms 143Colonic Neoplasms 140Carcinoma, Hepatocellular 137Anxiety Disorders 125Rectal Neoplasms 119Hematologic Neoplasms 116Multiple Myeloma 109Stomach Neoplasms 105Neoplasm Metastasis 100Precursor Cell Lymphoblastic Leukemia-Lymphoma 97Melanoma 93Depression 93Pain 89Urinary Bladder Neoplasms 88Glioblastoma 87Endometrial Neoplasms 87Disease 85Lymphoma 84Sarcoma 78

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Aortic Valve Stenosis × 1 year × Clear all
NCT06816888 2026-04-30

Echo Prompts

Ottawa Heart Institute Research Corporation

Phase NA Active not recruiting
300 enrolled
Lymphoid

Aortic Valve Stenosis, Heart Valve Diseases, Lymphoma, Follicular, Mitral Valve Insufficiency

NCT06650839 2026-01-07

POC for the Treatment of Subjects With Moderate AS Using Valvosoft® Non-Invasive Ultrasound Therapy

Cardiawave SA

Phase NA Withdrawn
Lymphoid

Aortic Valve Stenosis, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡